YA II PN, Ltd. 13D and 13G filings for Q BioMed Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-04 6:00 pm Sale | 2024-09-30 | 13G | Q BioMed Inc. QBIO | YA II PN, Ltd. | 0 0.000% | -10,207,532 (Position Closed) | Filing |
| 2023-01-03 3:45 pm Purchase | 2022-12-31 | 13G | Q BioMed Inc. QBIO | YA II PN, Ltd. | 10,207,532 9.990% | 7,033,441 (+221.59%) | Filing |
| 2023-01-03 3:28 pm Purchase | 2022-12-31 | 13G | Q BioMed Inc. QBIO | YA II PN, Ltd. | 425,502 9.990% | 213,943 (+101.13%) | Filing |
| 2022-01-11 5:12 pm Purchase | 2021-12-31 | 13G | Q BioMed Inc. QBIO | YA II PN, Ltd. | 211,559 9.990% | 66,049 (+45.39%) | Filing |
| 2022-01-11 4:35 pm Purchase | 2021-12-31 | 13G | Q BioMed Inc. QBIO | YA II PN, Ltd. | 3,174,091 9.990% | 489,140 (+18.22%) | Filing |
| 2021-06-15 10:45 am Purchase | 2021-06-08 | 13G | Q BioMed Inc. QBIO | YA II PN, Ltd. | 145,510 9.990% | 145,510 (New Position) | Filing |
| 2021-02-04 7:43 pm Purchase | 2020-12-31 | 13G | Q BioMed Inc. QBIO | YA II PN, Ltd. | 2,684,951 9.990% | 313,357 (+13.21%) | Filing |
| 2020-04-07 7:19 pm Purchase | 2020-03-31 | 13G | Q BioMed Inc. QBIO | YA II PN, Ltd. | 2,371,594 9.990% | 2,371,594 (New Position) | Filing |